Numinus Wellness Inc reported a big jump in its 1Q 2022 revenue just as Health Canada has expanded its Special Access Program to enable easier access to.
/PRNewswire/ VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has announced the results of two large scale.
AUSTIN, Texas, Jan. 20, 2022 /PRNewswire/ VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has announced the results of two large scale clinical studies, which show that the
VolitionRx (NYSE-A:VNRX) Limited has announced the results of two large clinical studies, which show that the company s flagship Nu.Q assays, when used in.
Numinus Wellness Inc reported a big jump in its 1Q 2022 revenue just as Health Canada has expanded its Special Access Program to enable easier access to.